Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glassman

Showing results (161-170 of 229) with videos related to

Pageof 23
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2018
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcroMarvin H Gee, Leah V Sibener, Michael E Birnbaum, et al.
JAMA Ophthalmology|July 25, 2014
Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema, Susan B Bressler, Allison R Edwards, et al.
JAMA Ophthalmology|October 23, 2018
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic RetinopathyLloyd Paul Aiello, Isoken Odia, Adam R Glassman, et al.
JAMA Ophthalmology|April 28, 2017
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and RanibizumabSusan B Bressler, Danni Liu, Adam R Glassman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 11, 2009
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Roy W Beck, Allison R Edwards, et al.
Ophthalmology Science|June 17, 2024
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available MeasuresAdam R Glassman, Mohamed Ashraf Elmasry, Darrell E Baskin, et al.
JAMA Ophthalmology|May 6, 2021
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical TrialAdam R Glassman, Wesley T Beaulieu, Maureen G Maguire, et al.
JAMA Ophthalmology|February 21, 2020
Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical TrialAdam R Glassman, Carl W Baker, Wesley T Beaulieu, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical TrialLee M Jampol, Isoken Odia, Adam R Glassman, et al.
Bone Marrow Transplantation|April 27, 1999
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphomaC H Moskowitz, S D Nimer, J R Glassman, et al.
Pageof 23

Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2018
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcroMarvin H Gee, Leah V Sibener, Michael E Birnbaum, et al.
JAMA Ophthalmology|July 25, 2014
Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema, Susan B Bressler, Allison R Edwards, et al.
JAMA Ophthalmology|October 23, 2018
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic RetinopathyLloyd Paul Aiello, Isoken Odia, Adam R Glassman, et al.
JAMA Ophthalmology|April 28, 2017
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and RanibizumabSusan B Bressler, Danni Liu, Adam R Glassman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 11, 2009
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Roy W Beck, Allison R Edwards, et al.
Ophthalmology Science|June 17, 2024
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available MeasuresAdam R Glassman, Mohamed Ashraf Elmasry, Darrell E Baskin, et al.
JAMA Ophthalmology|May 6, 2021
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical TrialAdam R Glassman, Wesley T Beaulieu, Maureen G Maguire, et al.
JAMA Ophthalmology|February 21, 2020
Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical TrialAdam R Glassman, Carl W Baker, Wesley T Beaulieu, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical TrialLee M Jampol, Isoken Odia, Adam R Glassman, et al.
Bone Marrow Transplantation|April 27, 1999
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphomaC H Moskowitz, S D Nimer, J R Glassman, et al.
Pageof 23